<?xml version="1.0" encoding="UTF-8"?>
<ref id="B57">
 <label>57</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Folegatti</surname>
    <given-names>P. M.</given-names>
   </name>
   <name>
    <surname>Ewer</surname>
    <given-names>K. J.</given-names>
   </name>
   <name>
    <surname>Aley</surname>
    <given-names>P. K.</given-names>
   </name>
   <name>
    <surname>Angus</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Becker</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Belij-Rammerstorfer</surname>
    <given-names>S.</given-names>
   </name>
  </person-group>
  <article-title>Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial</article-title>
  <source>
   <italic toggle="yes">The Lancet</italic>
  </source>
  <year>2020</year>
  <volume>369</volume>
  <issue>10249</issue>
  <fpage>467</fpage>
  <lpage>478</lpage>
  <pub-id pub-id-type="doi">10.1016/S0140-6736(20)31604-4</pub-id>
 </element-citation>
</ref>
